Deep Learning-Based Evaluation of Ultrasound Images for Benign Skin Tumors.
Source check: Source checked. Not independent scientific confirmation.
Finding: This retrospective, single-center diagnostic study uses a residual-plus-attention CNN to classify three histopathology-confirmed benign skin tumors from 698 ultrasound images. The source reports patient-grouped five-fold evaluation, 95.87% mean accuracy, 90.10% sensitivity and 96.23% specificity, with class-activation-map comparison to physician findings. The result is limited to this cohort and needs external validation.
Technology: 2. Materials and Methods, 2.4.1; 3. Results: 250 patients were assigned by patient to five groups, with pathology labels; the combined CNN is evaluated by five-fold cross-validation and CAM comparison.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- 2. Materials and Methods, 2.4.1; 3. Results: 250 patients were assigned by patient to five groups, with pathology labels; the combined CNN is evaluated by five-fold cross-validation and CAM comparison.
- Test and result
- 2. Materials and Methods, 2.4.1; 3. Results: 250 patients were assigned by patient to five groups, with pathology labels; the combined CNN is evaluated by five-fold cross-validation and CAM comparison.
- Limitation / still unknown
- 2. Materials and Methods, 2.4.1; 3. Results: 250 patients were assigned by patient to five groups, with pathology labels; the combined CNN is evaluated by five-fold cross-validation and CAM comparison.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://mdpi-res.com/d_attachment/sensors/sensors-23-07374/article_deploy/sensors-23-07374.pdf · https://api.crossref.org/works/10.3390/s23177374
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.